PTGX vs SHW · rev $269.8M vs P/E 29, rev $12.46B
Protagonist Therapeutics Inc (PTGX) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
PTGX currently screens at market cap $7.25B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the PTGX and SHW stock pages for the full models.
Not investment advice.